Angiogenesis: the VE-cadherin switch. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Trends in Cardiovascular Medicine Year : 2006

Angiogenesis: the VE-cadherin switch.


Because angiogenesis is a key step in a number of pathologic processes, including tumor growth and atherosclerosis, many research studies have investigated the regulatory signals active at various stages of vascular invasion. The differential activities of the endothelial junction protein vascular endothelial (VE)-cadherin reflect the versatile behavior of endothelial cells between vascular quiescence and angiogenesis. VE-cadherin function and signaling are deeply modified in proliferating cells, and this conversion is accompanied by phosphorylation of the protein on tyrosine residues and enhanced transcription of its gene. Recent advances in the complex interplay between protein tyrosine kinases and phosphatases regulating VE-cadherin phosphorylation and function are discussed in this review.
Fichier principal
Vignette du fichier
inserm-00398930_edited.pdf (231.22 Ko) Télécharger le fichier
WallezFig1Final.pdf (733.38 Ko) Télécharger le fichier
WallezRev.pdf (85.84 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)

Dates and versions

inserm-00398930 , version 1 (25-06-2009)



Yann Wallez, Isabelle Vilgrain, Philippe Huber. Angiogenesis: the VE-cadherin switch.. Trends in Cardiovascular Medicine, 2006, 16 (2), pp.55-9. ⟨10.1016/j.tcm.2005.11.008⟩. ⟨inserm-00398930⟩


376 View
1863 Download



Gmail Facebook X LinkedIn More